Press release
HIV Reservoirs Cure Workshop: Straight Line from CROI to Saint Martin
The ‘International Workshop on HIV Persistence’ has been a major source for those seeking information and guidance in a global effort to understand and eradicate HIV from its reservoirs.Toulon, France, February 18, 2011 -- The ‘International Workshop on HIV Persistence’ has been a major source for those seeking information and guidance in a global effort to understand and eradicate HIV from its reservoirs. Ever since its first edition in 2003, it has been recognized for its original ideas, vision and innovative qualities. Its organizers will meet in Boston at the end of this month in parallel of the Conference on Retroviruses and Opportunistic Infections (CROI) to define the scientific program of its next edition this December in Saint Martin.
The main focus of these workshops has been to understand and find out ways to tackle HIV reservoirs and finally eradicate HIV. Since its inception, this workshop has grown tremendously in terms of stature. It has taken rapid strides forward with all the participants being ever committed to finding a cure for HIV.
The participants at the ‘International Workshop on HIV Persistence’ include scientists, researchers and doctors who have achieved significant breakthroughs in HIV research during the past 15 years. The topics are designed to help understand the reasons for HIV persistence in its reservoir and also find out new and innovative strategies to help eradicate HIV from the infected hosts.
This workshop provides a platform for the leading scientists to interact and network with one another. It enables them to share information in order to gain a better understanding of the various mechanisms that allow for the maintenance of HIV reservoirs. The presentations at the workshop cover the very latest developments in the field of HIV persistence and reservoirs.
This workshop is held once every two years. More than 200 leading scientists are invited to be a part of it. This brings out the latest research developments out in the open so that the people at large know the advancements made in the battle against HIV.
The International Workshop on HIV Persistence is supported by ANRS, the French Agency for AIDS Research, Abbot Virology, Boehringer Ingelheim, Gilead, Janssen – Cilag, Bentham Science and ViiV Healthcare.
The 5th International Workshop on HIV Persistence is to be held at Radisson St. Martin Hotel, St. Martin, West Indies from December 6th to 9th December 2011.
For more information, please contact: Alain Lafeuillade, MD, PhD, Chair of the ‘International Workshop on HIV Persistence’. Chief, Department of Infectious Diseases and Clinical Research, General Hospital, Toulon, France. Ph: +33-494616340, email: lafeuillade@orange.fr; http://www.informedhorizons.com/persistence2011
For more information, please contact: Alain Lafeuillade, MD, PhD, Chair of the ‘International Workshop on HIV Persistence’. Chief, Department of Infectious Diseases and Clinical Research, General Hospital, Toulon, France. Ph: +33-494616340, email: lafeuillade@orange.fr; http://www.informedhorizons.com/persistence2011
Contact:
Alain Lafeuillade
Informed Horizons, LLC
Department of Infectious Diseases and Clinical Research, General Hospital,
Toulon, France
+33-4-94-616340
lafeuillade@orange.fr
http://www.informedhorizons.com/persistence2011
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HIV Reservoirs Cure Workshop: Straight Line from CROI to Saint Martin here
News-ID: 163047 • Views: …
More Releases from Informed Horizons, LLC
Scientists Move Towards A HIV Cure
Dr. Alain Lafeuillade and Dr. Mario Stevenson, are pleased to announce the 5th International Workshop on HIV Persistence During Therapy, to be held December 6-9, 2011 in St Maarten, West Indies. The Workshop will be of invaluable importance for scientists working towards a HIV cure.
Toulon, France, May 29, 2011 -- Dr. Alain Lafeuillade, Toulon, France and Dr. Mario Stevenson, University of Miami, USA are pleased to announce the 5th International…
Hope for a Cure Against HIV
Alain Lafeuillade (France) and Mario Stevenson (USA) co-authored a paper on HIV reservoirs that claims these reservoirs are the main hurdle to achieving HIV eradication. This paper provides information on the mechanisms of HIV persistence and a discussion on the critical questions facing researchers in the field.
Tucker, GA, May 28, 2011 -- Alain Lafeuillade (France) and Mario Stevenson (USA) co-authored a paper on HIV reservoirs that claims these reservoirs are…
New Discoveries Expected at the Scientific Workshop on HIV Reservoirs
Tucker, GA - April 21, 2011 -- Controlling HIV replication without the need of life-long antiretroviral therapy (ART) is the next frontier scientists are addressing. Researchers involved in the fields of HIV reservoirs and eradication have just released the preliminary program of a workshop they will organize later this year, where scientific breakthroughs are expected.
Fifteen years ago, when ART was discovered, a renewed optimism for a cure gained several scientists…
Researchers United to Find a HIV cure
HIV persistence is an area of importance to many scientists working on a possible cure for HIV, and every two years a reference workshop is held to bring the world's top scientists together for a meeting of the minds. Researchers from several different fields will therefore attend its next edition, December 6-9, 2011. The preliminary program of this workshop has just been released, and the four-day seminar is packed with…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…
